‘A slow and painful journey’: why did it take over 20 years to approve the new Alzheimer’s drug?

Authors

Ralph N. Martins, Edith Cowan UniversityFollow

Document Type

Article

Publication Title

The Conversation

Publisher

The Conversation Media Group Ltd

School

School of Medical and Health Sciences

Comments

Martins, R. (2021). ‘A slow and painful journey’: why did it take over 20 years to approve the new Alzheimer’s drug? The Conversation. https://theconversation.com/a-slow-and-painful-journey-why-did-it-take-over-20-years-to-approve-the-new-alzheimers-drug-162603

Access Rights

free_to_read

Creative Commons License

This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.